SCHEMBL9159602

SCHEMBL9159602

CCCCCCCCCCCCCCCCOCC(O)COC(c1ccccc1)(c1ccccc1)c1ccc(OC)cc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CASR P41180 2/20 0.47
PLA2G2A P14555 2/20 0.43
PLA2G10 O15496 1/20 0.43
PLA2G1B P04054 1/20 0.43
PLA2G5 P39877 1/20 0.43
USP2 O75604 1/20 0.43
PLA2G4B P0C869 2/20 0.42
HTT P42858 1/20 0.42
LPAR5 Q9H1C0 1/20 0.40
SLC6A1 P30531 2/20 0.40
SLC6A11 P48066 1/20 0.40
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
KIF11 P52732 1/20 0.38
KCNH2 Q12809 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15070694 1.00 CASR (0.47) CASRPLA2G2APLA2G10PLA2G1BPLA2G5
SCHEMBL13575129 1.00 CASR (0.47) CASRPLA2G2APLA2G10PLA2G1BPLA2G5
SCHEMBL9496434 1.00 CASR (0.47) CASRPLA2G2APLA2G10PLA2G1BPLA2G5
SCHEMBL9495170 1.00 CASR (0.47) CASRPLA2G2APLA2G10PLA2G1BPLA2G5
SCHEMBL16104620 1.00 CASR (0.47) CASRPLA2G2APLA2G10PLA2G1BPLA2G5
SCHEMBL30515121 1.00 CASR (0.47) CASRPLA2G2APLA2G10PLA2G1BPLA2G5
SCHEMBL10412255 0.98 CASR (0.46) CASRPLA2G2APLA2G10PLA2G1BPLA2G5
SCHEMBL17445655 0.94 CASR (0.43) CASRPLA2G2APLA2G10PLA2G1BPLA2G5
SCHEMBL9851905 0.92 CASR (0.43) CASRPLA2G2APLA2G10PLA2G1BPLA2G5
SCHEMBL25289434 0.92 USP2 (0.50) CASRPLA2G2APLA2G10PLA2G1BPLA2G5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5411983-A Certain hyrdoxy-phosphinyl-oxy-phenylmethyl-imidazolium hydroxide inner salts as PAF antagonists AMERICAN CYANAMID COMPANY (US) 1995-05-02 US disclosed
US-5234918-A For cardiovascular, respiratory, carcinogenic and inflammatory disorders AMERICAN CYANAMID COMPANY (US) 1993-08-10 US disclosed
US-5215975-A Certain hydroxy-phosphinyl-oxy-phenyl methyl-thiazolium hydroxide inner salts as PAF antagonists AMERICAN CYANAMID COMPANY (US) 1993-06-01 US disclosed
US-5208223-A Enzyme inhibitors AMERICAN CYANAMID COMPANY (US) 1993-05-04 US disclosed
US-5144045-A Treatment of inflammatory related disorders AMERICAN CYANAMID COMPANY (US) 1992-09-01 US disclosed
US-5126291-A Non-steroidal antiinflammatory agents AMERICAN CYANAMID COMPANY (US) 1992-06-30 US disclosed
US-4981989-A Antihypertensive phosphate derivatives and intermediates thereof AMERICAN CYANAMID COMPANY (US) 1991-01-01 US disclosed
US-4894367-A CARDIOVASCULAR DISORDERS AMERICAN CYANAMID COMPANY (US) 1990-01-16 US disclosed
US-4883816-A SULFONYL DERIVATIVES AMERICAN CYANAMID COMPANY (US) 1989-11-28 US disclosed
EP-0336142-A2 Novel antagonists of platelet activating factor AMERICAN CYANAMID COMPANY (US) 1989-10-11 EP disclosed
US-4762942-A AMINO SUBSTITUTED, INNER SALTS AMERICAN CYANAMID CO. (US) 1988-08-09 US disclosed